Skip to content

COmpliance Objectively measured in a Multicultural Population of children Living In Amsterdam Needing inhaled Corticosteroids for Effective asthmatreatment. (COMPLIANCE)

COmpliance Objectively measured in a Multicultural Population of children Living In Amsterdam Needing inhaled Corticosteroids for Effective asthmatreatment. (COMPLIANCE) - COMPLIANCE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32079
Enrollment
225
Registered
2008-10-06
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma bronchopulmonary hyperreactivity

Interventions

None listed

Sponsors

Sint Lucas Andreas Ziekenhuis
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Patient attending the pediatric outpatient department of the St. Lucas Andreas hospital or the Academic Medical Centre. - Patient has been treated with fluticason for at least 3 months using a pressurized metered-dose inhaler. - Maximum age: 11 years old. - Dutch, Moroccan, Turkish ethnicity.

Exclusion criteria

Exclusion criteria: - Patient refuses to participate in the study. - Patient is not capable of using the equipment for electronic measurement of compliance correctly#.;#These patient are requested to participate in the interview. In addition, patient characteristics are collected to investigate whether these patients differ from the ones that are capable of using the RTMEMS-equipment.

Design outcomes

Primary

MeasureTime frame
Electronically measured compliance is the primary outcome measure; the influence of the determinants on compliance will be analysed.

Secondary

MeasureTime frame
As a secondary outcome measure the accuracy of the information on compliance from the questionnaire will be compared to the RTMEMS.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)